USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Mar 8, 2022 | Dec 2021 | $-0.18 | $-0.18 | $-0.23 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Mar 8, 2022 | Dec 2021 | $0.00 | $0.00 | $0.00 |
Diamedica Therapeutics's next earnings date is Tuesday, Mar 8, 2022 for the fiscal quarter ending Dec 2021.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 5 | $-0.18 | $-0.22 | $-0.14 |
| Mar 2022 | 3 | $-0.25 | $-0.32 | $-0.19 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 5 | $-0.73 | $-0.76 | $-0.68 |
| Dec 2022 | 5 | $-1.01 | $-1.27 | $-0.72 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 4 / 0 | $-0.23 | $-0.23 | $-0.30 |
| Mar 2022 | 2 / 0 | $-0.30 | $-0.30 | $-0.35 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 4 / 0 | $-0.83 | $-0.83 | $-0.91 |
| Dec 2022 | 4 / 0 | $-1.13 | $-1.13 | $-1.32 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Dec 2021 | 5 | $0.00 | $0.00 | $0.00 |
| Mar 2022 | 3 | $0.00 | $0.00 | $0.00 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 5 | $0.00 | $0.00 | $0.00 |
| Dec 2022 | 5 | $0.00 | $0.00 | $0.00 |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 8, 2022 | Dec 2021 | $-0.18 | - | - |
| Nov 10, 2021 | Sep 2021 | $-0.23 | $-0.18 | 22.58% |
| Aug 11, 2021 | Jun 2021 | $-0.22 | $-0.17 | 21.30% |
| May 5, 2021 | Mar 2021 | $-0.22 | $-0.19 | 12.84% |
| Mar 10, 2021 | Dec 2020 | $-0.16 | $-0.23 | -41.54% |
| Nov 4, 2020 | Sep 2020 | $-0.15 | $-0.19 | -29.52% |
| Aug 11, 2020 | Jun 2020 | $-0.14 | $-0.17 | -25.93% |
| May 13, 2020 | Mar 2020 | $-0.29 | $-0.19 | 33.33% |
| Mar 23, 2020 | Dec 2019 | $-0.25 | $-0.21 | 16.00% |
| Nov 13, 2019 | Sep 2019 | $-0.21 | $-0.20 | 4.76% |
| Aug 13, 2019 | Jun 2019 | $-0.26 | $-0.21 | 18.19% |
| May 13, 2019 | Mar 2019 | $-0.20 | $-0.27 | -35.00% |
| Mar 19, 2019 | Dec 2018 | $-0.26 | $-0.11 | 57.69% |
| Dec 10, 2018 | Sep 2018 | - | $-0.07 | - |
| Aug 30, 2018 | Jun 2018 | - | $-0.46 | - |
| Apr 30, 2018 | Mar 2018 | - | $-0.09 | - |
| Nov 27, 2017 | Sep 2017 | - | $-0.15 | - |
| Aug 29, 2017 | Jun 2017 | - | $-0.18 | - |
| Apr 27, 2017 | Mar 2017 | - | $-0.24 | - |
| Nov 29, 2016 | Sep 2016 | - | $-0.20 | - |
| Aug 29, 2016 | Jun 2016 | - | $-0.12 | - |
| Apr 29, 2016 | Mar 2016 | - | $-0.08 | - |
| Nov 30, 2015 | Sep 2015 | - | $-0.07 | - |
| Aug 31, 2015 | Jun 2015 | - | $-0.10 | - |
| Apr 30, 2015 | Mar 2015 | - | $-0.14 | - |
| Nov 28, 2014 | Sep 2014 | $-0.20 | $-0.40 | -100.00% |
| Aug 28, 2014 | Jun 2014 | $-0.60 | $-0.40 | 33.33% |
| Apr 30, 2014 | Mar 2014 | $-0.40 | $-0.40 | - |
| Nov 28, 2013 | Sep 2013 | - | $-0.47 | - |
| Aug 28, 2013 | Jun 2013 | - | $-0.80 | - |
| Mar 31, 2013 | Mar 2013 | - | $-1.08 | - |
| Dec 31, 2012 | Dec 2012 | - | $-1.25 | - |
| Sep 30, 2012 | Sep 2012 | - | $-1.02 | - |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 10, 2021 | Dec 2020 | - | $-0.78 | - |
| Mar 23, 2020 | Dec 2019 | - | $-0.89 | - |
| Mar 19, 2019 | Dec 2018 | - | $-5.54 | - |
| Dec 31, 2012 | Dec 2012 | - | $-2.28 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 8, 2022 | Dec 2021 | $0.00 | - | - |
| Nov 10, 2021 | Sep 2021 | $0.00 | $0.00 | - |
| Aug 11, 2021 | Jun 2021 | $0.00 | $0.00 | - |
| May 5, 2021 | Mar 2021 | $0.00 | $0.00 | - |
| Mar 10, 2021 | Dec 2020 | $0.00 | $0.00 | - |
| Nov 4, 2020 | Sep 2020 | - | $0.00 | - |
| Aug 11, 2020 | Jun 2020 | - | $0.00 | - |
| May 13, 2020 | Mar 2020 | - | $0.00 | - |
| Mar 23, 2020 | Dec 2019 | - | $0.00 | - |
| Nov 13, 2019 | Sep 2019 | - | $0.00 | - |
| Aug 13, 2019 | Jun 2019 | - | $0.00 | - |
| May 13, 2019 | Mar 2019 | - | $0.00 | - |
| Mar 19, 2019 | Dec 2018 | - | $-3.66K | - |
| Dec 10, 2018 | Sep 2018 | - | $503.66K | - |
| Aug 30, 2018 | Jun 2018 | - | $0.00 | - |
| Apr 30, 2018 | Mar 2018 | - | $0.00 | - |
| Nov 27, 2017 | Sep 2017 | - | $0.00 | - |
| Aug 29, 2017 | Jun 2017 | - | $0.00 | - |
| Apr 27, 2017 | Mar 2017 | - | $0.00 | - |
| Nov 29, 2016 | Sep 2016 | - | $0.00 | - |
| Aug 29, 2016 | Jun 2016 | - | $0.00 | - |
| Apr 29, 2016 | Mar 2016 | - | $0.00 | - |
| Nov 30, 2015 | Sep 2015 | - | $0.00 | - |
| Aug 31, 2015 | Jun 2015 | - | $0.00 | - |
| Apr 30, 2015 | Mar 2015 | - | $0.00 | - |
| Nov 28, 2014 | Sep 2014 | - | $0.00 | - |
| Aug 28, 2014 | Jun 2014 | - | $0.00 | - |
| Apr 30, 2014 | Mar 2014 | - | $0.00 | - |
| Nov 28, 2013 | Sep 2013 | - | $0.00 | - |
| Aug 28, 2013 | Jun 2013 | - | $0.00 | - |
| Mar 31, 2013 | Mar 2013 | - | $0.00 | - |
| Dec 31, 2012 | Dec 2012 | - | $0.00 | - |
| Sep 30, 2012 | Sep 2012 | - | $0.00 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 10, 2021 | Dec 2020 | - | $0.00 | - |
| Mar 23, 2020 | Dec 2019 | - | $0.00 | - |
| Mar 19, 2019 | Dec 2018 | - | $500.00K | - |
| Dec 31, 2012 | Dec 2012 | - | $0.00 | - |
DMAC's next earnings date is Tuesday, Mar 8, 2022 for the fiscal quarter ending Dec 31, 2021.
According to 5 analysts, the average EPS estimation for Diamedica Therapeutics's next quarterly earnings is $-0.18, with a low EPS estimation of $-0.22, and a high estimation of $-0.14.
Over the last 1 month, EPS estimates have seen 4 upward revisions and 0 downward. The EPS 1 month trend is $-0.23, the last 2 month trend is $-0.23, and the 3 month trend is $-0.30.
Based on 5 analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.
Diamedica Therapeutics's previous earnings date was Nov 10, 2021 for its fiscal quarter ended Sep 30, 2021.
DMAC's earnings per share (EPS) was $-0.18, beating the consensus analysts forecast of $-0.23 by 22.58%.
The EPS was lower than the previous fiscal quarter (Jun 2021) by 5.88%, and higher than the same period a year before (Sep 2020) by -5.26%.
Revenues were $0.00.
The company reported a net income of $-3.45M.Free cash flow for the quarter was $-3.05M , compared to $-2.09M last quarter and $-2.35M a year before.
DMAC ended the quarter with $68.00K in total debt, a decrease of -20.00% compared to the previous quarter, and a decrease of -49.25% compared to the same quarter a year before.
Diamedica Therapeutics's previous annual earnings date was Mar 10, 2021 for its fiscal year ended Dec 31, 2020.
DMAC's earnings per share (EPS) was $-0.78.
Revenues were $0.00.
The company reported a net income of $-12.29M.
Diamedica Therapeutics reported a free cash flow of $-9.23M for its fiscal year, compared to $-9.10M a year ago.
The company ended the fiscal year with $72.00K in total debt, a decrease of -59.55% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
